Triumeq PD kit is a prescription medicine containing Abacavir, marketed by ViiV Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Abacavir
- Brand
- Triumeq PD
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- ViiV Healthcare
- Manufacturer
- ViiV Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F to 86°F). Store and dispense in the original package, protect from moisture, and keep the bottle tightly closed. Store and dispense in the original bottle, protect from moisture, and keep the bottle tightly closed.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF06 Abacavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 March 2022
- Identifiers
- RxCUI 1546888, 1546894, 2598348 +1DailyMed set ID 2997739a-aa91-42aa-a206-a70e2db7b84fNDC 49702-258Application NDA215413
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 90 tablet, film coated in 1 bottle | 49702-258-37 | ViiV Healthcare | 30 March 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Abacavir
Clinical summary
Abacavir is a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus (HIV-1) infection. It is available as tablets, oral solution and kits. MedsAcross supplies Abacavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AbacavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZIAGEN prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Ziagen: European public assessment report (EPAR) · European Medicines Agency
Need Triumeq PD kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.